BRACKETT, JOHN M.,JONAITIS, DAVID T.,LAI, WEI,LIU, JIH HUA,PARENT, STEPHAN D.,SHEN, JINYU
申请号：
PL07870091
公开号：
PL2102192T3
申请日:
2007.12.28
申请国别(地区):
PL
年份:
2013
代理人:
摘要：
The invention relates to crystalline forms of racemic ilaprazole, 2[[(4-methoxy-3-methyl-2-pyridinyl)-methyl]sulfinyl]-5-(1H-pyrrol-1-yl) 1H-Benzimidazole. The invention also relates to a pharmaceutical composition for inhibiting gastric acid secretion comprising a crystalline Form of ilaprazole according to the invention in an amount effective to inhibit gastric acid secretion and a pharmaceutically acceptable carrier. The invention also provides methods of treatment for various acid-related gastrointestinal (GI) disorders.
